BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, December 5, 2025
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 22, 2001
View Archived Issues
Combretastatin significantly potentiates the antitumor action of radioimmunotherapy
Read More
Phase II study of AC-2993 shows positive results for type 2 diabetes
Read More
Nicox's NCX-1000 protects against portal hypertension in preclinical study
Read More
ETA receptor antagonist attenuates angiotensin II- and noradrenaline-induced vasoconstriction
Read More
EGFR and HER-2 tyrosine kinase inhibitors with in vivo antitumor activity reported
Read More
Progesterone antagonists may provide a new option to suppress menstruation
Read More
Agreement to commercialize Anogesic announced by Cellegy and Ventiv
Read More
Addition of ZD-1839 to conventional maintenance therapy being evaluated in NSCLC patients
Read More
Abgenix and Agensys sign cancer immunotherapy collaboration
Read More
Long-term results emphasize Pravachol's good safety profile
Read More
Xenova and QLT sign licensing agreement for XR-9576
Read More
Atrix and HGSI to develop drug using Atrigel delivery system
Read More
Cognetix secures financing to further advance research and discovery efforts
Read More
Serono's Saizen approved in E.U. for treatment of adult growth hormone deficiency
Read More
Alliance Pharmaceutical submits documentation to the FDA regarding Imavist approval
Read More
Allergan's Botox approved for hyperhidrosis in the U.K.
Read More
FDA issues approvable letter for Arixtra
Read More
FDA approves labeling change for Pfizer's Zoloft
Read More
Compounds for delivery of biologically or chemically active agents designed at Emisphere
Read More
Kyoto Pharmaceuticals reports carbapenems active against respiratory and urinary tract infections
Read More
Novel MMP inhibitors disclosed by Aventis
Read More
Aventis develops a new series of Na+/H+ exchange inhibitors
Read More
FDA advisory committee recommends approval of Kineret for treatment of RA
Read More
Two series of glycogen synthase kinase 3 inhibitors patented by Chiron
Read More
Zometa approved by FDA for treatment of hypercalcemia of malignancy
Read More